13 Interstitial Lung Disease Clinical Trials in Kansas City, KS (2026)

Q: How do I join a clinical trial in Kansas City?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you.

Recruiting Interstitial Lung Disease Studies in Kansas City

NCT05392881Recruiting

Interstitial Lung Disease Research Unit Biobank

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease....

Kansas City, KS1,000 participantsUniversity of Kansas Medical Center

View Study Details

NCT05880199Recruiting

BSGM to Evaluate Patients With GI Symptoms

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with G...

Kansas City, KS685 participantsChildren's Hospital of Philadelphia

View Study Details

NCT07132411Recruiting

Talk With Me Baby: Leveraging Well-Child Care to Enhance the Early Home Language Environment

Language-rich interactions with a parent or caregiver can serve as a protective factor for young children, by supporting their language development and other positive long-term outcomes, but existing ...

Kansas City, KS400 participantsUniversity of Kansas Medical Center

View Study Details

NCT04571658Recruiting

NEPTUNE Match Study

NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physic...

Kansas City, KS375 participantsUniversity of Michigan

View Study Details

NCT06951217Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01. Eligible participants ...

Kansas City, KS340 participantsAvalyn Pharma Inc.

View Study Details

NCT06967805Recruiting

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

A Phase 2a, Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of MTX-463 in Participants with Idiopathic Pulmonary Fibrosis (IPF)...

Kansas City, KS164 participantsMediar Therapeutics

View Study Details

NCT05571059Recruiting

Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF....

Kansas City, KS128 participantsCumberland Pharmaceuticals

View Study Details

NCT06968845Recruiting

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Rationale: LTI-03 is an experimental medication breathed into the lungs using an inhaler. It is being studied for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is a progressive, fatal lung...

Kansas City, KS120 participantsRein Therapeutics

View Study Details

NCT07201922Recruiting

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

This study is open to people aged 40 years or older who have at least 1 family member with pulmonary fibrosis. Pulmonary fibrosis is a condition where lung tissue becomes scarred, making it harder to ...

Kansas City, KS80 participantsBoehringer Ingelheim

View Study Details

NCT06191640Recruiting

Sinus Disease in Young Children With Cystic Fibrosis

This is a prospective, observational study examining the impact of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators on chronic rhinosinusitis (CRS) and olfactory ...

Kansas City, KS80 participantsUniversity of California, Los Angeles

View Study Details

NCT06015191Recruiting

Remote Cardiac Rehab for Adolescents With Congenital Heart Disease

The goal of this randomized controlled trial is to evaluate the effectiveness of video conferencing for the delivery of live-supervised, real-time cardiac rehabilitation (CR) exercise training to grou...

Kansas City, KS74 participantsChildren's Mercy Hospital Kansas City

View Study Details

NCT07036523Recruiting

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

This study is open to adults who are at least 40 years old and have idiopathic pulmonary fibrosis (IPF). People can participate in the study if they have a forced vital capacity (FVC) greater than or ...

Kansas City, KS71 participantsBoehringer Ingelheim

View Study Details

NCT07330778Recruiting

A Study of CDX-622 in Participants With Mild to Moderate Asthma

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma....

Kansas City, KS12 participantsCelldex Therapeutics

View Study Details

About Interstitial Lung Disease Clinical Trials in Kansas City

Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.

There are currently 13 interstitial lung disease clinical trials recruiting participants in Kansas City, KS. These studies are seeking a combined 3,529 participants. Research is being sponsored by University of Kansas Medical Center, Children's Hospital of Philadelphia, University of Michigan and 8 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Interstitial Lung Disease Clinical Trials in Kansas City — FAQ

Are there interstitial lung disease clinical trials in Kansas City?

Yes, there are 13 interstitial lung disease clinical trials currently recruiting in Kansas City, KS. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Kansas City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Kansas City research site will contact you about next steps.

Are clinical trials in Kansas City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Kansas City studies also compensate for your time and travel.

What interstitial lung disease treatments are being tested?

The 13 active trials in Kansas City are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.

Data updated July 13, 2026 from ClinicalTrials.gov